180 related articles for article (PubMed ID: 20698574)
1. Vaccine delivery by polymeric vehicles in the mouse reproductive tract induces sustained local and systemic immunity.
Kuo-Haller P; Cu Y; Blum J; Appleton JA; Saltzman WM
Mol Pharm; 2010 Oct; 7(5):1585-95. PubMed ID: 20698574
[TBL] [Abstract][Full Text] [Related]
2. Per-oral immunization with antigen-conjugated nanoparticles followed by sub-cutaneous boosting immunization induces long-lasting mucosal and systemic antibody responses in mice.
Howe SE; Konjufca VH
PLoS One; 2015; 10(2):e0118067. PubMed ID: 25710518
[TBL] [Abstract][Full Text] [Related]
3. Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant.
Di Tommaso A; Saletti G; Pizza M; Rappuoli R; Dougan G; Abrignani S; Douce G; De Magistris MT
Infect Immun; 1996 Mar; 64(3):974-9. PubMed ID: 8641809
[TBL] [Abstract][Full Text] [Related]
4. Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16 L1 virus-like particle vaccine in thermosensitive mucoadhesive delivery systems.
Park JS; Oh YK; Kang MJ; Kim CK
J Med Virol; 2003 Aug; 70(4):633-41. PubMed ID: 12794729
[TBL] [Abstract][Full Text] [Related]
5. Intranasal HIV-1-gp160-DNA/gp41 peptide prime-boost immunization regimen in mice results in long-term HIV-1 neutralizing humoral mucosal and systemic immunity.
Devito C; Zuber B; Schröder U; Benthin R; Okuda K; Broliden K; Wahren B; Hinkula J
J Immunol; 2004 Dec; 173(11):7078-89. PubMed ID: 15557206
[TBL] [Abstract][Full Text] [Related]
6. Improvement of the systemic prime/oral boost strategy for systemic and local responses.
Lauterslager TG; Stok W; Hilgers LA
Vaccine; 2003 Mar; 21(13-14):1391-9. PubMed ID: 12615435
[TBL] [Abstract][Full Text] [Related]
7. Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649-684), a mucosal subunit HIV/AIDS vaccine candidate.
Matoba N; Geyer BC; Kilbourne J; Alfsen A; Bomsel M; Mor TS
Vaccine; 2006 Jun; 24(23):5047-55. PubMed ID: 16621185
[TBL] [Abstract][Full Text] [Related]
8. Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule.
Gherardi MM; Pérez-Jiménez E; Nájera JL; Esteban M
J Immunol; 2004 May; 172(10):6209-20. PubMed ID: 15128809
[TBL] [Abstract][Full Text] [Related]
9. Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus.
Gallichan WS; Rosenthal KL
Vaccine; 1995 Nov; 13(16):1589-95. PubMed ID: 8578847
[TBL] [Abstract][Full Text] [Related]
10. Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations.
Cristillo AD; Ferrari MG; Hudacik L; Lewis B; Galmin L; Bowen B; Thompson D; Petrovsky N; Markham P; Pal R
J Gen Virol; 2011 Jan; 92(Pt 1):128-40. PubMed ID: 21169215
[TBL] [Abstract][Full Text] [Related]
11. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
Patel GB; Zhou H; Ponce A; Chen W
Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
[TBL] [Abstract][Full Text] [Related]
12. Mucosal inoculation of Lactobacillus expressing hCGbeta induces an anti-hCGbeta antibody response in mice of different strains.
Yao XY; Yuan MM; Li DJ
Methods; 2006 Feb; 38(2):124-32. PubMed ID: 16414267
[TBL] [Abstract][Full Text] [Related]
13. Oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation: particle size study.
Uchida T; Goto S
Biol Pharm Bull; 1994 Sep; 17(9):1272-6. PubMed ID: 7841952
[TBL] [Abstract][Full Text] [Related]
14. Mucosal application of gp140 encoding DNA polyplexes to different tissues results in altered immunological outcomes in mice.
Mann JF; McKay PF; Arokiasamy S; Patel RK; Tregoning JS; Shattock RJ
PLoS One; 2013; 8(6):e67412. PubMed ID: 23826293
[TBL] [Abstract][Full Text] [Related]
15. Female reproductive tract immunity in bovine trichomoniasis.
Corbeil LB; Anderson ML; Corbeil RR; Eddow JM; BonDurant RH
Am J Reprod Immunol; 1998 Mar; 39(3):189-98. PubMed ID: 9526608
[TBL] [Abstract][Full Text] [Related]
16. Lack of antigen-specific immune responses in anti-IL-7 receptor alpha chain antibody-treated Peyer's patch-null mice following intestinal immunization with microencapsulated antigen.
Kunisawa J; Takahashi I; Okudaira A; Hiroi T; Katayama K; Ariyama T; Tsutsumi Y; Nakagawa S; Kiyono H; Mayumi T
Eur J Immunol; 2002 Aug; 32(8):2347-55. PubMed ID: 12209648
[TBL] [Abstract][Full Text] [Related]
17. Systemic and Mucosal Antibody Responses to Soluble and Nanoparticle-Conjugated Antigens Administered Intranasally.
Howe SE; Sowa G; Konjufca V
Antibodies (Basel); 2016 Oct; 5(4):. PubMed ID: 31558001
[TBL] [Abstract][Full Text] [Related]
18. Mucosal immunization with inactivated HIV-1-capturing nanospheres induces a significant HIV-1-specific vaginal antibody response in mice.
Akagi T; Kawamura M; Ueno M; Hiraishi K; Adachi M; Serizawa T; Akashi M; Baba M
J Med Virol; 2003 Feb; 69(2):163-72. PubMed ID: 12683403
[TBL] [Abstract][Full Text] [Related]
19. Generation of female genital tract antibody responses by local or central (common) mucosal immunization.
Wu HY; Abdu S; Stinson D; Russell MW
Infect Immun; 2000 Oct; 68(10):5539-45. PubMed ID: 10992451
[TBL] [Abstract][Full Text] [Related]
20. Controlled release microparticles for vaccine development.
O'Hagan DT; Jeffery H; Roberts MJ; McGee JP; Davis SS
Vaccine; 1991 Oct; 9(10):768-71. PubMed ID: 1759495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
